[Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection].
Juszczyk
Jacek
J
Boroń-Kaczmarska
Anna
A
Cianciara
Janusz
J
Flisiak
Robert
R
Gładysz
Andrzej
A
Halota
Waldemar
W
Kryczka
Wiesław
W
Małkowski
Piotr
P
Pawłowska
Małgorzata
M
Simon
Krzysztof
K
D000998:Antiviral Agents / Q000627:therapeutic use*; D019468:Disease Management; D006297:Health Services Accessibility / Q000458:organization & administration; D006509:Hepatitis B / Q000188:drug therapy; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D011044:Poland; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000458:organization & administration; D011320:Primary Health Care / Q000458:organization & administration*; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D019259:Lamivudine